rituximab,ibrutinib,Bendamustine
biogen,roche,novartis,janssen,abbvie
['improve', 'rituximab', 'shine', 'lymphoma', 'mantle,(-dismantle)']
#asco22 lba502: the phase iii shine clinical trial led by dr. michael wang found that ibrutinib plus bendamustine-rituximab improved progression-free survival in mantle cell lymphoma patients over age 65: #endcancer 
The official account of MD Anderson Cancer Center, a leader in cancer care, cancer research and the fight to #EndCancer. Appointments available: 1-877-632-6789.